Valuation IOL Chemicals and Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. 13:22:57 02/11/2026 +03			5-day change	1st Jan Change
180.45 ^INR	+1.52%		+10.43%	+119.39%

11:05am	IOL Chemicals and Pharmaceuticals Limited, Q2 2027 Earnings Call, Nov 02, 2026
10-30	IOL Chemicals and Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2023	2024	2025	2026	2027	2028
Market Cap ¹	16,608	21,222	17,964	21,354	52,967	-
Change	-	27.78%	-15.35%	18.87%	148.04%	-
Enterprise Value (EV)	16,608	21,222	17,964	21,354	52,967	52,967
Change	-	27.78%	-15.35%	18.87%	148.04%	0%
P/E	11.9x	15.8x	17.8x	15.5x	24.1x	17.4x
PBR	1.1x	1.32x	1.06x	1.19x	2.7x	2.43x
PEG	-	-4.68x	-0.7x	0.4x	0.4x	0.5x
Capitalization / Revenue	0.75x	1x	0.86x	0.92x	1.93x	1.63x
EV / Revenue	0x	0x	0x	0x	1.93x	1.63x
EV / EBITDA	0x	0x	0x	0x	14.5x	-
EV / EBIT	0x	0x	0x	0x	15x	11.9x
EV / FCF	-0x	0x	-0x	0x	19.1x	25.9x
FCF Yield	-5.39%	0.78%	-1.94%	1.94%	5.24%	3.86%
Dividend per Share ²	0.8	1	4	-	-	-
Rate of return	1.41%	1.38%	6.54%	-	-	-
EPS ²	4.74	4.58	3.44	4.69	7.5	10.4
Distribution rate	16.9%	21.8%	116%	-	-	-
Net sales ¹	22,171	21,328	20,792	23,191	27,424	32,403
EBITDA ¹	2,257	2,306	2,023	2,690	3,647	-
EBIT ¹	2,051	1,677	1,303	1,887	3,535	4,451
Net income ¹	1,391	1,344	1,011	1,376	2,198	-
Net Debt	-	-	-	-	-	-
Reference price ²	56.58	72.30	61.20	72.75	180.45	180.45
Nbr of stocks (in thousands)	293,528	293,528	293,528	293,528	293,528	-
Announcement Date	4/28/23 A	5/14/24 A	5/16/25 A	5/20/26 A	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IOL CHEMICALS AND PHARMACEUTICALS LIMITED	23.7x	-	-	-	549M
ELI LILLY AND COMPANY	41.42x	14.01x	31.06x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	36.71x	8.6x	17.71x	2.35%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	97.38x	6.07x	25.8x	2.28%	369B
NOVARTIS AG	23.19x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.47x	4.89x	13.87x	1.77%	290B
AMGEN INC.	29.55x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-40.86x	7.45x	46.76x	1.94%	212B
Average	29.73x	7.39x	21.67x	2.01%	426.25B
Weighted average by Cap.	36.40x	8.82x	22.82x	1.69%